CD274 and neoplasm: This metabolite specifically targets and stabilizes PD-L1, which suppresses the activity of tumor-infiltrating T lymphocytes and leads to increased recruitment and activity of polymorphonuclear myeloid-derived suppressor cells (PMN-MDSCs) and tumor-associated macrophages (TAMs) (46).